REVAXIS 0,5ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

revaxis 0,5ml ενεσιμο εναιωρημα

sanofi pasteur europe, france (0000011723) 14 espace henry vallee, lyon, 69007 - purified diphteria toxoid; purified tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium hydroxide - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 0,5ml - ineof00246 purified diphteria toxoid 2.000000 iu; ineof00247 purified tetanus toxoid 20.000000 iu; ineof00249 inactivated poliovirus vacc type i 40.000000; ineof00250 inactivated poliovirus vacc type ii 8.000000; ineof00251 inactivated poliovirus vacc type iii 32.000000; 0021645512 aluminium hydroxide 0.350000 mg - diphtheria-poliomyelitis-tetanus

PENTAVAC (ΕΜΒΟΛΙΟ) INJ.SUSP 0,5ml (1DOSE) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

pentavac (εμβολιο) inj.susp 0,5ml (1dose)

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified tetanus toxoid; purified diphteria toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; haemophilus type b polysac. conjugated to tetanus protein - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ); pd.inj.sus (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 0,5ml (1dose) - purified tetanus toxoid 40iu; purified diphteria toxoid 20iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; haemophilus type b polysac. conjugated to tetanus protein 10mcg - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

VIATIM (ΔΙΠΛΟ ΕΜΒΟΛΙΟ ΗΠΑΤΙΤΙΔΑΣ A-ΤΥΦΟΕΙΔΟΥΣ ΠΥΡ INJ.SUSP Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

viatim (διπλο εμβολιο ηπατιτιδασ a-τυφοειδουσ πυρ inj.susp

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - salmonella typhi, purified capsular polysaccharide vi; hepatitis a, virus, purified inactivated - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - salmonella typhi, purified capsular polysaccharide vi 0,025mg; hepatitis a, virus, purified inactivated 160u - typhoid-hepatitis a

TETRAVAC (ΕΜΒΟΛΙΟ) INJ.SUSP (1ΔΟΣΗ)0,5ML PF.SYR. Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

tetravac (εμβολιο) inj.susp (1δοση)0,5ml pf.syr.

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified diphteria toxoid; purified tetanus toxoid; purified pertussis toxoid (pt xd); filamentous haemagglutinin (fha); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (1ΔΟΣΗ)0,5ml pf.syr. - purified diphteria toxoid 20iu; purified tetanus toxoid 40iu; purified pertussis toxoid (pt xd) 25mcg; filamentous haemagglutinin (fha) 25mcg; inactivated poliovirus vacc type i 29du; inactivated poliovirus vacc type ii 7du; inactivated poliovirus vacc type iii 26du - diphtheria-pertussis-poliomyelitis-tetanus

ACT-HIB PS.INJ.SOL 10MCG/0.5ML Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

act-hib ps.inj.sol 10mcg/0.5ml

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - haemophilus type b polysac. conjugated to tetanus protein - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 10mcg/0.5ml - haemophilus type b polysac. conjugated to tetanus protein 10mcg - hemophilus influenzae b, purified antigen conjugated

VAXIGRIP (ΑΝΤΙΓΡΙΠΠΙΚΟ) (15+15+15)MCG/0,5ML PF.SYR (1 δόση) ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

vaxigrip (αντιγριππικο) (15+15+15)mcg/0,5ml pf.syr (1 δόση) ενεσιμο εναιωρημα σε προγεμισμενη συριγγα

sanofi pasteur europe, france (0000011723) 14 espace henry vallee, lyon, 69007 - a/brisbane/02/2018 (h1n1) pdm09 - like strain (a/brisbane/02/2018, ivr-190); a/kansas/14/2017 (h3n2)- like strain (a/kansas/14/2017, nymc x-327); b/colorado/06/2017- like strain (b/maryland/15/2016, nymc bx-69a) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - (15+15+15)mcg/0,5ml pf.syr (1 δόση) - ineof02495 a/brisbane/02/2018 (h1n1) pdm09 - like strain (a/brisbane/02/2018, ivr-190) 15.000000 mcg; ineof02496 a/kansas/14/2017 (h3n2)- like strain (a/kansas/14/2017, nymc x-327) 15.000000 mcg; ineof2566 b/colorado/06/2017- like strain (b/maryland/15/2016, nymc bx-69a) 15.000000 mcg - influenza, purified antigen

DIFTAVAX® INJ.SUSP (2+20)IU (ADULTS) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

diftavax® inj.susp (2+20)iu (adults)

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - purified diphteria toxoid; purified tetanus toxoid - inj.susp (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - (2+20)iu (adults) - purified diphteria toxoid 2iu; purified tetanus toxoid 20iu - tetanus toxoid, combinations with diphtheria toxoid

VAXIGRIP TETRA® INJ.SU.PFS (15+15+15+15)MCG/0.5ML PF.SYR (1 δόση). Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

vaxigrip tetra® inj.su.pfs (15+15+15+15)mcg/0.5ml pf.syr (1 δόση).

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221); b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11); b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - (15+15+15+15)mcg/0.5ml pf.syr (1 δόση). - a/victoria/2570/2019 (h1n1) pdm09 - like strain (a/victoria/2570/2019, ivr-215) 15mcg; a/cambodia/e0826360/2020 (h3n2) - like strain a/tasmania/503/2020, ivr-221) 15mcg; b/washington/02/2019 - like strain (b/victoria/705/2018/bvr-11) 15mcg; b/phuket/3073/2013 – like strain(b/phuket/3073/2013, wild type) 15mcg - influenza, purified antigen

REPEVAX INJ.SU.PFS Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

repevax inj.su.pfs

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - diphtheria toxoid, adsorbed; tetanus toxoid, adsorbed; purified pertussis toxoid (pt xd); adsorbed purified filamentous haemagglutinin (fha); adsorbed purified pertactin (prn); adsorbed purified fimbrial agglutinogens 2+3 (fim); inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; aluminium phosphate - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - diphtheria toxoid, adsorbed 2iu; tetanus toxoid, adsorbed 20iu; purified pertussis toxoid (pt xd) 2,5mcg; adsorbed purified filamentous haemagglutinin (fha) 5mcg; adsorbed purified pertactin (prn) 3mcg; adsorbed purified fimbrial agglutinogens 2+3 (fim) 5mcg; inactivated poliovirus vacc type i 29u; inactivated poliovirus vacc type ii 7u; inactivated poliovirus vacc type iii 26u; aluminium phosphate 1,5mg - diphtheria-pertussis-poliomyelitis-tetanus

TRIAXIS INJ.SU.PFS 0,5ML (1 DOSE) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

triaxis inj.su.pfs 0,5ml (1 dose)

sanofi pasteur europe, france 14 espace henry vallee, 69007 lyon +33 437 28 40 00 - diphtheria toxoid, adsorbed; tetanus toxoid, adsorbed; pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); fimbriae types 2 and 3 absorbed (fim); aluminium phosphate - inj.su.pfs (ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - 0,5ml (1 dose) - diphtheria toxoid, adsorbed 2iu; tetanus toxoid, adsorbed 20iu; pertussis toxoid (pt) 2,5mcg; filamentous haemagglutinin (fha) 5mcg; pertactin (69 kda outer membrane protein-69k) 3mcg; fimbriae types 2 and 3 absorbed (fim) 5mcg; aluminium phosphate 1,5mg - pertussis, purified antigen, comb. with toxoids